Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sumitaka Hagiwara"'
Autor:
Naoya Itoh, Nana Akazawa, Yuichi Ishibana, Shunsuke Hamada, Sumitaka Hagiwara, Hiromi Murakami
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Campylobacter rectus is a gram-negative rod, and Parvimonas micra is a gram-positive coccus, both of which are oral anaerobes that cause chronic periodontitis. Chronic periodontitis can cause bacteremia and systemic diseases, incl
Externí odkaz:
https://doaj.org/article/ed9315ecf4354faf9b49c9d237ca16cf
Autor:
Sumitaka Hagiwara, Eiichi Sasaki, Yasuhisa Hasegawa, Hidenori Suzuki, Daisuke Nishikawa, Shintaro Beppu, Hoshino Terada, Michi Sawabe, Masahide Takahashi, Nobuhiro Hanai
Publikováno v:
Cancer Medicine, Vol 10, Iss 4, Pp 1335-1346 (2021)
Abstract Background Various biomarkers are being developed for the early diagnosis of cancer and for predicting its prognosis. The aim of this study is to evaluate the diagnostic significance of serum CD109 in head and neck squamous cell carcinoma (H
Externí odkaz:
https://doaj.org/article/e9872661f570443a83cb2cd62405ea5d
Autor:
Hidenori Suzuki, Eiichi Sasaki, Ryota Nakamura, Michi Sawabe, Sumitaka Hagiwara, Ikuo Hyodo, Nobuhiro Hanai
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 3462-3466 (2020)
Abstract This case report describes a mandibular ameloblastoma with both BRAF V600E mutation and rare hypercalcemia. The patient without distant metastasis underwent subtotal mandibulectomy using double flaps of fibula and anterolateral thigh. A whol
Externí odkaz:
https://doaj.org/article/7175e3281f54449c84cd86caaa06dcad
Autor:
Hidenori, Suzuki, Mai, Yokoi, Sumitaka, Hagiwara, Eiichi, Sasaki, Yoshiaki, Kobayashi, Sho, Iwaki, Daisuke, Nishikawa, Shintaro, Beppu, Hoshino, Terada, Michi, Sawabe, Nobuhiro, Hanai
Publikováno v:
Anticancer Research. 42:1653-1657
During the COVID-19 pandemic, pedicle flaps instead of free flap transfer were recommended for head and neck reconstruction to reduce infection risk. Boron neutron-capture therapy in Japan was clinically approved in 2020 as a salvage radiotherapy for
Autor:
Masahide Takahashi, Nobuhiro Hanai, Hidenori Suzuki, Michi Sawabe, Eiichi Sasaki, Sumitaka Hagiwara, Shintaro Beppu, Daisuke Nishikawa, Yasuhisa Hasegawa, Hoshino Terada
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 4, Pp 1335-1346 (2021)
Cancer Medicine, Vol 10, Iss 4, Pp 1335-1346 (2021)
Background Various biomarkers are being developed for the early diagnosis of cancer and for predicting its prognosis. The aim of this study is to evaluate the diagnostic significance of serum CD109 in head and neck squamous cell carcinoma (HNSCC). Me
Autor:
Naoya Itoh, Nana Akazawa, Yuichi Ishibana, Shunsuke Hamada, Sumitaka Hagiwara, Hiromi Murakami
Publikováno v:
BMC infectious diseases. 22(1)
Background Campylobacter rectus is a gram-negative rod, and Parvimonas micra is a gram-positive coccus, both of which are oral anaerobes that cause chronic periodontitis. Chronic periodontitis can cause bacteremia and systemic diseases, including ost
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 31:98-102
Dentigerous cysts (DC) are the second most common odontogenic cysts of the jaw and are usually associated with the crowns of impacted or unerupted teeth. In particular, DCs tend to occur around unerupted mandibular third molars and maxillary mesioden
Publikováno v:
Toukeibu Gan. 45:286-293
Autor:
Hiroki Sakakura, Yoshiki Murakumo, Shinji Mii, Sumitaka Hagiwara, Takuya Kato, Masato Asai, Akiyoshi Hoshino, Noriyuki Yamamoto, Sayaka Sobue, Masatoshi Ichihara, Minoru Ueda, Masahide Takahashi
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e83385 (2014)
CD109, a glycosylphosphatidylinositol-anchored glycoprotein, is expressed at high levels in some human tumors including squamous cell carcinomas. As CD109 is reportedly cleaved by furin and its soluble form is secreted into culture medium in vitro, w
Externí odkaz:
https://doaj.org/article/dba7e8a07b364f97b6d6a7f7f3587e5a
Autor:
Masaya Hattori, Masahiko Tachi, Masashi Andoh, Yasunari Mizuno, Kenichi Yoshimura, Hiroji Iwata, Sumitaka Hagiwara, Susumu Hijioka, Haruru Kotani, Naomi Gondo, Junichi Shimizu, Michiko Tatematsu, Yayoi Adachi, Akiyo Yoshimura, Masataka Sawaki
Publikováno v:
International journal of clinical oncology. 24(10)
Everolimus is a mammalian target of rapamycin inhibitor used in the treatment of multiple tumor types, and its most common toxicity, stomatitis, can affect patient quality of life. Recent studies in breast cancer have supported the efficacy of steroi